Johnson & Johnson

• Richard Cervone of Putnam Tax-Smart Equity Fund

  By Staff Writer  |  February 15, 2005

  S&P Rank: 5 Stars Tax-Aware Fund Seeks Good Fundamentals First

• Lanny Thorndike and Kevin Callahan of Century Shares Trust

  By Staff Writer  |  January 12, 2005

  S&P Rank: 4 Stars Stable Value With a Growth Tint

• Richard Skaggs of Loomis Sayles Growth Fund

  By Staff Writer  |  December 20, 2004

  S&P Rank: 5 Stars Picking Up Steam

• John C. Thompson of Thompson Plumb Growth Fund

  By Staff Writer  |  August 27, 2004

  S&P Rank: 5 Stars Growth, By Any Other Name

• Fund in Focus: Smith Barney Fundamental Value Fund

  By Staff Writer  |  July 19, 2004

  July 16, 2004 -- The Smith Barney Fundamental Value/A (SHFVX) began buying large pharmaceuticals companies late last year. At that time, their stocks were trading...

• Evan McCulloch of Franklin Biotechnology Discovery Fund

  By Staff Writer  |  March 24, 2004

  S&P Rank: 3 Stars March 11, 2004 Biotechs High on Drug Approvals

• Robert Millen of the Jensen Fund

  By Staff Writer  |  August 25, 2003

  S&P Rank: 3 Stars Aug. 18, 2003 Steady and Rising Quick Take: It's not what it owns, but what it doesn't own that has weighed on the Jensen...

• Liu-Er Chen of Evergreen Health Care Fund

  By Staff Writer  |  August 25, 2003

  S&P Rank: 4 Stars Aug. 14, 2003 On the Cusp of a New Drug Boom Quick Take: Drug and biotech stocks suffered in 2002, hurt by poor earnings,...

• Steve Calhoun of Fidelity Select Health Care Portf

  By Staff Writer  |  March 27, 2003

  Good Prognosis for Medical Devices S&P Rank:

• Michael Yellen of AIM Global Health Care Fund

  By Staff Writer  |  January 31, 2003

  S&P Rank: 4 Stars Good Prognoses for Drug Stocks